Journal of Cardiovascular and Thoracic Research最新文献

{"title":"Investigating ethnic differences in risk factors and severity of developing premature coronary artery disease: Predicting the effect of risk factors through decision tree analysis in a multicenter case-control study; Results from Iran Premature Coronary Artery Disease (IPAD study).","authors":"Seyed Ali Moezi Bady, Fatemeh Salmani, Ehsan Zarepur, Toba Kazemi, Neda Partovi, Nazanin Hanafi Bojd, Saeede Khosravi Bizhaem, Alireza Khosravi Farsani, Noushin Mohammadifard, Fereidoon Nouhi, Hassan Alikhasi, Masoumeh Sadeghi, Hamidreza Roohafza, Razieh Hassannejad, Katayoun Rabiei, Nahid Salehi, Kamal Solati, Masoud Lotfizadeh, Samad Ghaffari, Elmira Javanmardi, Arsalan Salari, Mostafa Dehghani, Mostafa Cheraghi, Habib Haybar, Reza Madadi, Nahid Azdaki, Nizal Sarrafzadegan","doi":"10.34172/jcvtr.025.33190","DOIUrl":"10.34172/jcvtr.025.33190","url":null,"abstract":"<p><strong>Introduction: </strong>Premature coronary artery disease (PCAD) has an ascending trend especially in developing countries. This study have investigated the risk factors and severity of developing CAD across various Iranian ethnicities.</p><p><strong>Methods: </strong>This case-control study was done on 3015 Iranian patients undergoing coronary artery angiography, across highly populated Iranian ethnicities including Bakhtiari, Azari, Qashqai, Arab, Fars, Kurd, Gilak, and Lur. This study was performed over three years in 14 capitals of provinces in Iran headed by Isfahan Cardiovascular Research Center, by including men≤60 years old and women≤70 years undergoing coronary artery angiography. If they had coronary stenosis above 75% (more than 50% in the left main), they were categorized as Case group.The effects of conventional risk factors as well as psychosocial ones including age, gender, weight, Body mass index (BMI), economic status, cigarette smoking, drugs of abuse, stress, anxiety, diabetes, hypertension, etc. were determined in each ethnicity using decision tree statistical method. Also, via logistic regression method, the odds of incidence of CAD in each ethnicity were specified against the Fars ethnicity (the predominant ethnicity in Iran).</p><p><strong>Results: </strong>The most common risk factor among different ethnicities was age and male gender. Also, among the Iranian ethnicities, Kurd had the lowest chance while Gilak and Azari had the highest chance of developing PCAD as compared to the Fars ethnicity. Investigation of the behavioral and psychological dimensions indicated that stress was significantly higher among those without coronary artery involvement as compared to those with this involvement. The decision tree model could predict that among Gilakis, Fasting blood sugar (FBS) above 126 and in Lurs opium as well as diastolic blood pressure above 85, and in Kurds male gender would considerably increase the odds of developing CAD.</p><p><strong>Conclusion: </strong>The model obtained from the decision tree indicated that although variables of age, gender, cigarette, and opium are among the main risk factors for involvement of coronary arteries among young adult patients, in different ethnicities, the risk level of each of these risk factors in incidence of PCAD is different. This means among Kurds, age, among Gilakis diabetes, and among Lurs opium are more important.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"17 1","pages":"49-57"},"PeriodicalIF":1.2,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144002407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and efficacy of Evermine50 Everolimus-eluting coronary stent system in patients with native coronary artery lesions: Three-year outcomes from a single-center.","authors":"Suresh V Patted","doi":"10.34172/jcvtr.025.33123","DOIUrl":"10.34172/jcvtr.025.33123","url":null,"abstract":"<p><strong>Introduction: </strong>The Evermine50^TM (Meril Life Sciences Pvt. Ltd., India) is the world's thinnest strut (50 µm) featuring a biodegradable polymer-based Everolimus-eluting stent (EES) system. We present the 3-year safety and performance outcomes of Evermine50 EES.</p><p><strong>Methods: </strong>This was a prospective, post-marketing, single-center study of patients with native coronary artery lesions (CAL) in real-world settings. Patients with symptomatic ischemic heart disease due to <i>de novo</i> and in-stent restenotic lesions (lengths<44mm) in native coronary arteries with reference vessel diameters of 2.0 - 4.5 mm. and eligible for stenting procedure with percutaneous transluminal coronary angioplasty were included.</p><p><strong>Results: </strong>A total of 251 patients (mean age: 58.20 years) were enrolled, of which 48.2% had ST-elevation myocardial infarction and 31.5% had silent ischemia. The mean lesion length was 21.81±8.14 mm, and 70.3% of patients had pre-procedure Thrombolysis in Myocardial Infarction (TIMI) flow grade III. The average and stent length was recorded as 23.50±12.21 mm. In 98% of patients, post-procedural TIMI-III flow grade was achieved. The cumulative rate of major adverse cardiac events defined as composite of cardiac death, target vessel myocardial infarction, and clinically-driven target lesion revascularization (CD-TLR) at 1, 2, and 3 years were 1.59%, 3.58%, and 3.58%, respectively. The cumulative rates of CD-TLR remained constant at 0.79% from 1 to 3 years. There were no cases of stent thrombosis until 3 years.</p><p><strong>Conclusion: </strong>This study demonstrated favorable safety and performance of the ultrathin Evermine50 EES at 36 months in patients with native CAL.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"17 1","pages":"58-65"},"PeriodicalIF":1.2,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of flaxseed in reducing blood pressure among patients with cardiovascular risk factors: A systematic review and meta-analysis of parallel randomized controlled trials.","authors":"Refli Hasan, Raed Obaid Saleh, Rana H Raheema, Hanen Mahmod Hulail, Irfan Ahmad, Deepak Nathiya, Parjinder Kaur","doi":"10.34172/jcvtr.025.33280","DOIUrl":"10.34172/jcvtr.025.33280","url":null,"abstract":"<p><p>The prevalence rate of hypertension is on the rise at an alarming rate. Studies conducted on the influence of flaxseed on blood pressure (BP) have come up with conflicting conclusions. The current investigation's major purpose is to conduct a literature review and a meta-analysis focusing on the effect of flaxseed supplementation on BP in people with cardiovascular disease (CVD) risk factors. PubMed, Scopus, Web of Science, and Cochrane Central Library databases were searched from the inception date to April 2024 to find the randomized controlled trials (RCTs). A random-effects model combined the weighted mean difference (WMD). Standard methodologies were applied to evaluate publication bias, heterogeneity, and sensitivity analysis. Eighteen RCTs were included in the present systematic review and meta-analysis. Pooled analysis suggested that flaxseed supplementation can reduce systolic BP (SBP) (WMD: -4.75 mmHg, 95% CI: -7.05 to -2.44, <i>P</i>≤0.001; I²=93.6%) and diastolic BP (DBP) (WMD: -3.09 mmHg, 95% CI: -4.37 to -1.81, <i>P</i>≤0.001; I²=91.2%). In conclusion, the current meta-analysis has demonstrated that flaxseed supplementation can markedly lower BP in individuals exhibiting CVD risk factors. Given the significant heterogeneity, it is crucial to interpret the current results with careful consideration. In addition, further high-quality RCTs are required to better assess the causal relationships.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"17 1","pages":"1-11"},"PeriodicalIF":1.2,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trans-thoracic echocardiographic findings after the closure of ostium secundum atrial septal defect: A six-month follow-up study.","authors":"Leila Bigdelu, Naser Nezhad Biglari, Yoones Ghaderi, Ali Azari, Maryam Emadzadeh, Mohsen Moohebati, Nadia Azadi, Vafa Baradaran Rahimi","doi":"10.34172/jcvtr.025.32997","DOIUrl":"10.34172/jcvtr.025.32997","url":null,"abstract":"<p><strong>Introduction: </strong>Adults with an atrial septal defect (ASD) have the third most frequent congenital heart disease. We aimed to determine the echocardiography findings after the defect closure in patients with ostium secundum ASD.</p><p><strong>Methods: </strong>We included patients who underwent the closure of ostium secundum ASD using trans-catheter or surgical procedures. All patients were subjected to transthoracic echocardiography at admission, one month, and six months following successful closure. The remaining shunt were measured using contrast echocardiography and none of our patients had the remaining shunt.</p><p><strong>Results: </strong>We evaluated 28 patients with a mean age of 35.67±11.55 years. Twelve (42.85%) individuals had trans-catheter, and 16 (57.14%) patients had surgical closure of ASD. After ASD closure, the left ventricular (LV) ejection fraction (<i>P</i>=0.02), and LV end-diastolic diameter significantly increased while S'_TAPSE, right atrial (RA) area, RA volume, and pulmonary artery pressure (PAP) markedly diminished (<i>P</i><0.001). During follow-up, RV size changes showed a significant decrease during one (17.93%) and six (25.78%) months (<i>P</i><0.001 for both cases) and become normal following six months after the ASD closure. In addition, the RA/LA area ratio dropped by 24.31% during the first month and 33.17% after six months (<i>P</i><0.001). In addition, the changes in measured echocardiographic parameters were not significantly different over time between the trans-catheter and surgical procedures. The decrease in S'_TAPSE was significantly greater in the surgical group than in trans-catheter closure.</p><p><strong>Conclusion: </strong>Closure of ostium secundum ASD dramatically decreased right cardiac chamber size and PAP while enhancing LV diameter and LV ejection fraction.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"17 1","pages":"27-34"},"PeriodicalIF":1.2,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An unusual thrombus in a patient with arrhythmogenic cardiomyopathy.","authors":"Sezgin Atmaca, Arda Guler, İrem Türkmen, Sinem Aydın, Songul Ustundag, Gamze Babur Guler","doi":"10.34172/jcvtr.025.33140","DOIUrl":"10.34172/jcvtr.025.33140","url":null,"abstract":"<p><p>Herein we present a case of a right ventricular (RV) thrombus in a patient with arrhythmogenic cardiomyopathy (ACM). The 24-year old female patient was diagnosed with ACM after echocardiography, genetic test and cardiac magnetic resonance imaging. Interestingly, at echocardiography, an unusal thrombus formation was detected at RV lateral wall. Also, CMR confirmed the thrombus and oral anticoagulant therapy was started. During the patient's follow-ups, it was observed that the imaging consistent with the reported thrombus disappeared after effective anticoagulant treatment. After the diagnosis was confirmed with genetic tests, an implantable cardioverter-defibrillator (ICD) was implanted in the patient with a high sudden cardiac death (SCD) risk score. Even in arrhythmogenic right ventricular cardiomyopathy patients thrombi are rarely reported. However, the development of imaging techniques may enable more frequent detection and effective treatment of thrombi in these patients.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"17 1","pages":"66-69"},"PeriodicalIF":1.2,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144011539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial.","authors":"Hossein Behzad, Sina Mashayekhi, Hila Asham, Parvin Sarbakhsh, Taher Entezari-Maleki","doi":"10.34172/jcvtr.33103","DOIUrl":"https://doi.org/10.34172/jcvtr.33103","url":null,"abstract":"<p><strong>Introduction: </strong>Percutaneous Coronary Intervention (PCI) is a fundamental procedure for coronary artery disease management, yet the risk of adverse events such periprocedural myocardial injury (PMI) persists. This double-blind, randomized clinical trial aims to assess the efficacy of empagliflozin in preventing myocardial injury during PCI procedure.</p><p><strong>Methods: </strong>A total of 90 patients were randomly assigned to two groups A and B; Group A as the intervention group received empagliflozin 25 mg 24 hours before and empagliflozin 10 mg 1-2 hours before coronary intervention and group Bas the control group received placebo at similar intervals. The primary outcome involved comparing baseline, 8-hour, and 24-hour cTnI and baseline and 24-hour hs-CRP levels after PCI in both groups to measure the incidence of periprocedural myocardial injury (PMI) and anti-inflammatory effects of empagliflozin.</p><p><strong>Results: </strong>Baseline cTnI levels with <i>P</i>=0.955, 8 hours after PCI with <i>P</i>=0.469, and 24 hours after the intervention with <i>P</i>=0.980 were not statistically different in the two groups. Baseline levels of hs-CRP in both intervention and control groups were not statistically significantly different (<i>P</i>=0.982). Also, there was no statistically significant difference in hs-CRP levels 24 hours after PCI in two groups (<i>P</i>=0.198). Finally, the results showed that MACEs did not occur in any of the groups.</p><p><strong>Conclusion: </strong>The results of this trial could not express the advantages of acute pretreatment with empagliflozin in preventing PCI-related myocardial injury.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"16 2","pages":"113-119"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142288096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effect of mannitol on postoperative renal function in patients undergoing coronary artery bypass surgery: A double-blinded randomized controlled trial.","authors":"Masumeh Hemmati Maslakpak, Eisa Bilejani, Sohrab Negargar, Ahmadali Khalili, Vahid Alinejad, Amir Faravan","doi":"10.34172/jcvtr.32992","DOIUrl":"10.34172/jcvtr.32992","url":null,"abstract":"<p><strong>Introduction: </strong>Mannitol, an osmotic diuretic solution, is commonly utilized in priming cardiopulmonary bypass (CPB) and can impact kidney function. This study was conducted to investigate the impact of mannitol use during CPB on kidney function in patients undergoing coronary artery bypass surgery.</p><p><strong>Methods: </strong>This randomized, double-blind clinical trial studied 90 patients undergoing coronary artery bypass surgery. In the control group (n=45), the prime solution included Ringer's lactate, and in the intervention group (n=45), the prime solution had 200 ml of mannitol 20% and Ringer's lactate. A <i>P</i>-value<0.05 was considered significant. The primary endpoint of this study is renal function.</p><p><strong>Results: </strong>Demographic characteristics and risk factors were not significantly different between the two groups (<i>P</i>>0.05). Additionally, there was no statistically significant difference between two groups in terms of CPB time, aortic cross-clamp time, length of time connected to mechanical ventilation, 30-day mortality, ICU, and hospital stay time (<i>P</i>>0.05). Furthermore, no statistically significant difference was observed between the two groups in serum creatinine levels (<i>P</i>=0.53) or BUN levels (<i>P</i>=0.13). The study also found no statistically significant difference in the diuresis rate between the two groups (<i>P</i>=0.10).</p><p><strong>Conclusion: </strong>The present study has shown that adding mannitol to the prime has no effect on kidney function, length of time connected to mechanical ventilation, length of stay in the ICU, or 30-day mortality. Therefore, it suggests that mannitol cannot be used as a preventative strategy for acute kidney injury after cardiac surgery.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"16 3","pages":"146-151"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142466345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between small dense low-density lipoprotein and carotid intima-media thickness.","authors":"Mohsen Khosravi, Farhad Sheikhnia, Mohammad Reza Pashaei, Maryam Karimi-Dehkordi, Shahin Alizadeh-Fanalou","doi":"10.34172/jcvtr.33145","DOIUrl":"https://doi.org/10.34172/jcvtr.33145","url":null,"abstract":"<p><p>Cardiovascular disease (CVD) and atherosclerosis are major causes of mortality worldwide. Early and accurate diagnosis of vascular thickening by predictive markers can help reduce the death rate of these diseases. Low-density lipoprotein (LDL) particles, which are rich in cholesterol, are regarded as key biomarkers for CVD and atherosclerosis. Numerous studies have demonstrated that pattern B (small dense LDL, sdLDL) is more atherogenic than LDL and can serve as a superior quantitative marker for CVD than LDL. Furthermore, several studies have indicated that carotid intima-media thickness (cIMT) is a reliable marker for the early detection of CVD and atherosclerosis in various populations. This review examines the relationship between sdLDL concentration and cIMT. It is concluded that sdLDL concentration has a positive correlation with cIMT, and their combined use can facilitate a more precise assessment of the diseases, especially atherosclerosis.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"16 4","pages":"202-210"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11866774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The changes in cardiovascular disease risk factors after the implementation of the package of essential non-communicable disease control.","authors":"Ali Reza Pouramini, Fatemeh Kafi, Reza Khadivi","doi":"10.34172/jcvtr.33127","DOIUrl":"10.34172/jcvtr.33127","url":null,"abstract":"<p><strong>Introduction: </strong>The Package of Essential Non-Communicable (PEN) Disease Control was implemented in the primary healthcare system to manage cardiovascular disease (CVD) risk factors in Iran. This study aimed to evaluate the status of CVD risk factor control following the implementation of the PEN.</p><p><strong>Methods: </strong>This historical cohort study was conducted among 60-65-year-old residents to compare hypertension (HTN) control via mean systolic blood pressure (SBP) and diastolic blood pressure (DBP), diabetes mellitus (DM) control via fasting blood sugar (FBS) and HbA1C tests, hyperlipidemia control via serum cholesterol and triglyceride levels, and overweight and obesity via body mass index (BMI) measurement in 2016 (before the implementation of the PEN project) and 2021 (after 5 years).</p><p><strong>Results: </strong>A total of 1,583 residents with a mean age of 62.32±1.70 years were included in the study. In 2021, compared to 2016, there was a significant decrease in the relative frequency of residents with high SBP from 13.7% to 9.3%, high DBP from 11.3% to 3.4%, FBS≥126 mg/dL from 25.6% to 19.7%, and BMI≥30 from 25.7% to 23.4%. Additionally, the mean DBP and the mean serum levels of FBS among all participants decreased significantly. However, the relative frequency of residents with total cholesterol≥200 mg/dL increased significantly from 11.5% to 14.2%.</p><p><strong>Conclusion: </strong>Following the implementation of the PEN, the control of HTN, DM, and obesity improved among 60-65-year-old residents. However, the control of hypercholesterolemia did not improve.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"16 3","pages":"179-183"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142466343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vascular decellularization dynamics: Optimizing Triton X-100 and SDS concentration with incubation time.","authors":"Umer Bin Shahzad, Ume Aiman, Muhammad Ahmed Sheikh","doi":"10.34172/jcvtr.33164","DOIUrl":"10.34172/jcvtr.33164","url":null,"abstract":"","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"16 3","pages":"200-201"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142466348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}